RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population

Psychiatry Clin Neurosci 55(4):373-377 · 2001 · PMID 11442888

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

164편 검색→153편 판독→62편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: CYP2D6 gene polymorphism and risk of Parkinson disease and Alzheimer disease (CYP2D6[tiab] OR "cytochrome P450 2D6"[tiab] OR CYP2D6*[tiab]) AND (polymorphism[tiab] OR polymorphisms[tiab] OR variant[tiab] OR variants[tiab] OR genotype[tiab] OR allele[tiab]) AND (("Parkinson disease"[tiab] OR Parkinson[tiab] OR parkinsonian[tiab]) OR ("Alzheimer disease"[tiab] OR Alzheimer[tiab] OR "Alzheimer's"[tiab]))

출판 연도

1992: 2편219921993: 3편31994: 2편21995: 5편519951996: 6편61997: 2편21998: 7편71999: 7편72000: 2편220002001: 4편42003: 1편12004: 2편220052006: 1편12007: 4편42008: 2편22010: 1편120102011: 1편12012: 1편12013: 1편12014: 3편32015: 1편120152017: 1편120202022: 1편12023: 1편12025: 1편12025

선별된 62편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01mutant · debrisoquine22편

  1. 0.94

    CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population 이 논문

    Woo SI, Kim JW, Seo HG et al. · Psychiatry and clinical neurosciences · 2001

  2. 0.94

    No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population

    Scordo MG, Dahl ML, Spina E et al. · Pharmacological research · 2006

  3. 0.93

    CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modification

    Cervilla JA, Russ C, Holmes C et al. · Biological psychiatry · 1999

  4. 0.93

    Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease

    Smith CA, Gough AC, Leigh PN et al. · Lancet (London, England) · 1992

  5. 0.92

    Cytochrome P4502D6 (debrisoquine 4-hydroxylase) and Parkinson's disease in Chinese and Caucasians

    Ho SL, Kung MH, Li LS et al. · European journal of neurology · 1999

  6. 0.92

    Debrisoquine hydroxylase and Parkinson's disease

    Kondo I, Kanazawa I · Advances in neurology · 1993

  7. 0.92

    Mutant debrisoquine hydroxylation genes in Parkinson's disease

    Armstrong M, Daly AK, Cholerton S et al. · Lancet (London, England) · 1992

  8. 0.91

    A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease

    Tsuneoka Y, Matsuo Y, Iwahashi K et al. · Journal of biochemistry · 1993

  9. 0.91

    CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study

    Harhangi BS, Oostra BA, Heutink P et al. · Movement disorders : official journal of the Movement Disorder Society · 2001

  10. 0.90

    Genetic polymorphism and Parkinson's disease in Taiwan: study of debrisoquine 4-hydroxylase (CYP2D6)

    Lo HS, Chen CH, Hogan EL et al. · Journal of the neurological sciences · 1998

  11. 0.90

    The HhaI polymorphism in the CYP2D6 gene is not associated with Parkinson's disease in a Caucasian population

    Nicholl DJ, Bennett P, Ramsden DB et al. · European journal of neurology · 1995

  12. 0.89

    CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia

    Golab-Janowska M, Honczarenko K, Gawronska-Szklarz B et al. · Neurologia i neurochirurgia polska · 2007

  13. 0.89

    Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease

    Plante-Bordeneuve V, Davis MB, Maraganore DM et al. · Journal of neurology, neurosurgery, and psychiatry · 1994

  14. 0.89

    Genetic analysis of the CYP2D6 gene in patients with Parkinson's disease

    Tsuneoka Y, Matsuo Y, Ichikawa Y et al. · Metabolism: clinical and experimental · 1998

  15. 0.89

    The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease

    Saitoh T, Xia Y, Chen X et al. · Annals of neurology · 1995

  16. 0.88

    Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease

    Pang CP, Zhang J, Woo J et al. · Movement disorders : official journal of the Movement Disorder Society · 1998

  17. 0.86

    Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13?

    Wilhelmsen K, Mirel D, Marder K et al. · Annals of neurology · 1997

  18. 0.85

    Frequency of a specific cytochrome P4502D6B (CYP2D6B) mutant allele in clinically differentiated groups of patients with Parkinson disease

    Akhmedova SN, Pushnova EA, Yakimovsky AF et al. · Biochemical and molecular medicine · 1995

  19. 0.83

    The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease

    Chen X, Xia Y, Alford M et al. · Annals of neurology · 1995

  20. 0.76

    ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guam

    Chen X, Xia Y, Gresham LS et al. · Neurology · 1996

  21. 0.59

    Rate of cognitive decline in Alzheimer's disease is not affected by the alpha-1-antichymotrypsin A allele or the CYP2D6 B mutant

    Murphy GMJ, Yang L, Yesavage J et al. · Neuroscience letters · 1996

  22. 0.51

    No evidence of an association between CYP2D6 polymorphisms among Japanese and dementia with Lewy bodies

    Furuno T, Kawanishi C, Iseki E et al. · Psychiatry and clinical neurosciences · 2001

02odds · confidence interval18편

  1. 0.94

    Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson's disease: a case control study

    Anwarullah, Aslam M, Badshah M et al. · Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2017

  2. 0.92

    The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis

    McCann SJ, Pond SM, James KM et al. · Journal of the neurological sciences · 1997

  3. 0.92

    Genotyping of CYP2D6 in Parkinson's disease

    Stefanovic M, Topic E, Ivanisevic AM et al. · Clinical chemistry and laboratory medicine · 2000

  4. 0.91

    CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease

    Elbaz A, Levecque C, Clavel J et al. · Annals of neurology · 2004

  5. 0.90

    Polymorphism in environment responsive genes and association with Parkinson disease

    Singh M, Khan AJ, Shah PP et al. · Molecular and cellular biochemistry · 2008

  6. 0.89

    Absence of effect of seven functional mutations in the CYP2D6 gene in Parkinson's disease

    Joost O, Taylor CA, Thomas CA et al. · Movement disorders : official journal of the Movement Disorder Society · 1999

  7. 0.89

    Genetic predisposition to Parkinson's disease: CYP2D6 and HFE in the Faroe Islands

    Halling J, Petersen MS, Grandjean P et al. · Pharmacogenetics and genomics · 2008

  8. 0.89

    Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease

    Maraganore DM, Farrer MJ, Hardy JA et al. · Movement disorders : official journal of the Movement Disorder Society · 2000

  9. 0.89

    Parkinson's disease, CYP2D6 polymorphism, and age

    Payami H, Lee N, Zareparsi S et al. · Neurology · 2001

  10. 0.88

    Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease

    Santt O, Baranova H, Albuisson E et al. · European journal of neurology · 2004

  11. 0.88

    CYP2D6 allelic frequencies in young-onset Parkinson's disease

    Sandy MS, Armstrong M, Tanner CM et al. · Neurology · 1996

  12. 0.74

    Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease

    Vilar R, Coelho H, Rodrigues E et al. · European journal of neurology · 2007

  13. 0.64

    Genetic and environmental risk factors for Parkinson's disease in a Chinese population

    Chan DK, Woo J, Ho SC et al. · Journal of neurology, neurosurgery, and psychiatry · 1998

  14. 0.62

    CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis

    Lu Y, Mo C, Zeng Z et al. · PloS one · 2013

  15. 0.61

    Parkinson's disease and CYP2D6 polymorphism in Asian populations: A meta-analysis

    Persad AS, Stedeford T, Tanaka S et al. · Neuroepidemiology · 2003

  16. 0.61

    Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study

    Dick FD, De Palma G, Ahmadi A et al. · Occupational and environmental medicine · 2007

  17. 0.55

    Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis

    Lu Y, Qin X, Li S et al. · Journal of the neurological sciences · 2014

  18. 0.52

    Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease

    Rostami-Hodjegan A, Lennard MS, Woods HF et al. · Pharmacogenetics · 1998

03mutations · frequencies11편

  1. 0.93

    Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease

    Tanaka S, Chen X, Xia Y et al. · Neurology · 1998

  2. 0.92

    Association between the oxidative polymorphism and early onset of Parkinson's disease

    Agundez JA, Jimenez-Jimenez FJ, Luengo A et al. · Clinical pharmacology and therapeutics · 1995

  3. 0.92

    The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease

    Gasser T, Muller-Myhsok B, Supala A et al. · Journal of neurology, neurosurgery, and psychiatry · 1996

  4. 0.92

    Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families

    Lucotte G, Turpin JC, Gerard N et al. · American journal of medical genetics · 1996

  5. 0.92

    CYP2D6 polymorphism and Parkinson's disease susceptibility

    Sabbagh N, Brice A, Marez D et al. · Movement disorders : official journal of the Movement Disorder Society · 1999

  6. 0.91

    Lack of relation between genetic polymorphism of cytochrome P-450IID6 and sporadic idiopathic Parkinson's disease

    Bordet R, Broly F, Destee A et al. · Clinical neuropharmacology · 1996

  7. 0.89

    Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease

    Kurth MC, Kurth JH · American journal of medical genetics · 1993

  8. 0.88

    Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease

    Bordet R, Broly F, Destee A et al. · Clinical neuropharmacology · 1994

  9. 0.87

    No association between familial Alzheimer disease and cytochrome P450 polymorphisms

    Yamada H, Dahl ML, Viitanen M et al. · Alzheimer disease and associated disorders · 1998

  10. 0.85

    A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism

    Nicholl DJ, Bennett P, Hiller L et al. · Neurology · 1999

  11. 0.62

    A CYPome-wide study reveals new potential players in the pathogenesis of Parkinson's disease

    Hartz P, Fehlmann T, Wagenpfeil G et al. · Frontiers in pharmacology · 2022

04cytochrome p450 · 2d69편

  1. 0.94

    CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease

    Atkinson A, Singleton AB, Steward A et al. · Pharmacogenetics · 1999

  2. 0.93

    Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease

    Singh M, Khanna VK, Shukla R et al. · Disease markers · 2010

  3. 0.91

    Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism

    Bon MA, Jansen Steur EN, de Vos RA et al. · Neuroscience letters · 1999

  4. 0.90

    Gene-gene and gene-environment interaction on the risk of Parkinson's disease

    Singh NK, Banerjee BD, Bala K et al. · Current aging science · 2014

  5. 0.86

    Polymorphism in Cytochrome P450 2D6, Glutathione S-Transferases Pi 1 Genes, and Organochlorine Pesticides in Alzheimer Disease: A Case-Control Study in North Indian Population

    Singh NK, Banerjee BD, Bala K et al. · Journal of geriatric psychiatry and neurology · 2014

  6. 0.83

    Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease

    Bialecka M, Klodowska-Duda G, Honczarenko K et al. · Parkinsonism & related disorders · 2007

  7. 0.81

    Quantitative and causal analysis for inflammatory genes and the risk of Parkinson's disease

    Yi M, Li J, Jian S et al. · Frontiers in immunology · 2023

  8. 0.60

    The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients

    Mann A, Miksys SL, Gaedigk A et al. · Neurobiology of aging · 2012

  9. 0.54

    Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis

    Factor SA, Steenland NK, Higgins DS et al. · Journal of neurology, neurosurgery, and psychiatry · 2011

05pharmacogenetic · drug1편

  1. 0.73

    Variants in Neurotransmitter-Related Genes Are Associated with Alzheimer's Disease Risk and Cognitive Functioning but Not Short-Term Treatment Response

    Zuniga-Santamaria T, Perez-Aldana BE, Fricke-Galindo I et al. · Neurology international · 2025

06donepezil · treatment1편

  1. 0.50

    Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease and mixed dementia: a one-year naturalistic study

    Miranda LFJR, Gomes KB, Silveira JN et al. · Journal of Alzheimer's disease : JAD · 2015